<?xml version="1.0" encoding="UTF-8"?>
<ref id="B37-vaccines-07-00053">
 <label>37.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Roldao</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Mellado</surname>
    <given-names>M.C.M.</given-names>
   </name>
   <name>
    <surname>Castilho</surname>
    <given-names>L.R.</given-names>
   </name>
   <name>
    <surname>Carrondo</surname>
    <given-names>M.J.T.</given-names>
   </name>
   <name>
    <surname>Alves</surname>
    <given-names>P.M.</given-names>
   </name>
  </person-group>
  <article-title>Virus-like particles in vaccine development</article-title>
  <source>Expert Rev. Vaccines</source>
  <year>2010</year>
  <volume>9</volume>
  <fpage>1149</fpage>
  <lpage>1176</lpage>
  <pub-id pub-id-type="doi">10.1586/erv.10.115</pub-id>
  <pub-id pub-id-type="pmid">20923267</pub-id>
 </element-citation>
</ref>
